Cost-effectiveness study of three antimalarial drug combinations in Tanzania.

BACKGROUND: As a result of rising levels of drug resistance to conventional monotherapy, the World Health Organization (WHO) and other international organisations have recommended that malaria endemic countries move to combination therapy, ideally with artemisinin-based combinations (ACTs). Cost is...

Full description

Bibliographic Details
Main Authors: Virginia Wiseman, Michelle Kim, Theonest K Mutabingwa, Christopher J M Whitty
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2006-10-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC1592341?pdf=render